Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Gennemførlighed af et multimodalt interventionsprogram til optimering af behandlingsresultater ved colitis ulcerosa (OPTIMIZE-UC)

17. september 2026 opdateret af: Radboud University Medical Center

OPTIMIZE-UC: Gennemførligheden af ​​et multimodalt interventionsprogram til optimering af behandlingsresultater ved colitis ulcerosa: et prospektivt pilotstudie

This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in Ulcerative Colitis (UC) patients with active disease as well as in patients in remission. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Rationale: Despite considerable advances in the knowledge of UC, and a variation of treatment options, UC still impacts patients' ability to lead a normal life. Clearly, there is an unmet need to improve treatment outcomes. Prehabilitation programs in surgery have shown that the amount of complications is closely related to preoperative physical fitness, nutritional status and psychological well-being. IBD patients often search for self-management strategies to manage their symptoms, however, research focussing on a multimodal intervention approach in parallel to starting new IBD treatment is lacking. Given the potential benefits of intervention programs, limitations of current treatments in terms of improving quality of life and patients' desire for self-management options, we believe that exploring the results of a multimodal intervention program in patients with UC is of high relevance.

Objective/study design: This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in UC patients. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes.

Study population: Patients ≥ 18 years old, with UC. Intervention: Multimodal intervention program including an exercise program, nutritional intervention and psychological evaluation.

Main study parameters/endpoints: This study assesses the feasibility of a multimodal intervention program. Secondary, assesses the effect on:

  • Individual patients' level, i.e. physical fitness, nutritional status, mental health, quality of life and work productivity and activity impairment.
  • Therapy outcomes, e.g. adherence, number and severity of (S)AEs, corticosteroid use, biochemical and clinical response/remission rates and patient reported outcomes.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

30

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Nijmegen, Holland, 6525GA
        • Dorien Oomkens

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Age ≥ 18 years old;
  • Diagnosis of UC confirmed by clinical, endoscopic, and/or histological evidence prior to screening as per standard criteria;
  • Ability of subject to participate fully in all aspects of this project;
  • Written informed consent must be obtained and documented.

Exclusion Criteria:

  • Suspicion of differential diagnosis of CD, indeterminate colitis, ischemic colitis, radiation colitis, diverticular disease associated with colitis, or microscopic colitis;
  • Serious underlying disease other than UC that in the opinion of the investigator may interfere with the subject's ability to participate fully in the study or would compromise subject safety (such as history of malignancies, major neurological disorders, certain orthopedic impairments or any unstable, uncontrolled or severe systemic medical disorder);
  • History of alcohol or drug abuse that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures;
  • History of psychiatric disorders that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures;
  • If female, the subject is pregnant or lactating (< 1 year) or intending to become pregnant;
  • Immobilized patients who are not able to complete exercise intervention;
  • Illiteracy (disability to read and understand Dutch).

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Patients with ulcerative colitis

Patients participate in multimodal intervention

Exercise intervention: combined endurance and resistance training three times a week using workout video's which patients can do at home. Advice to exercise at low-intensity for at least 30 minutes per day.

Nutritional intervention: Patients are advised to aim for optimal energy and protein intake (by registered dietician) and to avoid red meat, processed foods and sweetened drinks. Aiming for a mainly plant based diet.

Psychological intervention: screening for psychological risk factors and if present, patients are referred to a psychologist for psychological support.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Accrural
Tidsramme: 24 weeks

The percentage of approached, eligible participants that are included in the study.

24 weeks
Attrition
Tidsramme: 24 weeks

The percentage of participants who stopped the program prematurely.

24 weeks
Adherence to exercise program
Tidsramme: 24 weeks

Frequency of followed trainings

24 weeks
Adherence to daily exercise goals
Tidsramme: 24 weeks

SQUASH questionnaire

24 weeks
Patient satisfaction
Tidsramme: 24 weeks

Measured using a patient satisfaction questionnaire

24 weeks
Safety and adverse events
Tidsramme: 24 weeks

Measured by the number of adverse events occurring during the program

24 weeks

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in Oxygen Consumption (VO2 max)
Tidsramme: 1 year

Indication of physical fitness

1 year
Change in 1 repitition measures
Tidsramme: 1 year

Indication of muscle strength

1 year
Change in body weight
Tidsramme: 1 year

Measured in kilograms

1 year
Change in fat-free mass
Tidsramme: 1 year

Measured with bioelectrical impedance analysis (BIA)

1 year
Change in nutritional status
Tidsramme: 1 year

Measured with Patient Generated Subjective Global Assessment (PG-SGA)

1 year
Change in mental health
Tidsramme: 1 year

Hospital Anxiety and Depression scale (HADS questionnaire)

1 year
Change in Work Productivity and Activity Impairment
Tidsramme: 1 year

Work Productivity and Activity Impairment Questionnaire (including WPAI-GH)

1 year
Change in 36-Item Short Form Health Survey (SF-36) score
Tidsramme: 1 year

Quality of life

1 year
Change in EuroQoL (EQ-5D-5L) score
Tidsramme: 1 year

Quality of life

1 year
Change in Inflammatory Bowel Disease Questionnaire score
Tidsramme: 1 year

Disease-related quality of life

1 year

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. marts 2024

Primær færdiggørelse (Faktiske)

1. marts 2025

Studieafslutning (Faktiske)

1. marts 2026

Datoer for studieregistrering

Først indsendt

20. januar 2023

Først indsendt, der opfyldte QC-kriterier

14. februar 2023

Først opslået (Faktiske)

24. februar 2023

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

22. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

17. september 2026

Sidst verificeret

1. januar 2023

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 114110

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .